180 LIFE SCIENCES CORP.

EDGAR

Annual consolidated revenue for 2025: about USD 6.547M, using the latest reported figures.

Watchlist

Latest quarter

Revenue

1.37 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating margin

-728.35%

2026 Q2 · %

Exact inputs and evidence
  • Operating Income: -9942000 USD Source
  • Revenue: 1365000 USD Source

Operating cash flow

-12.4 million USD

2026 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: -32892000 USD Source
  • Operating Cash Flow: -20450000 USD Source

Free cash flow

-12.4 million USD

2026 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: -32892000 USD Source
  • Operating Cash Flow: -20450000 USD Source
  • Capital Expenditure: 16813000 USD Source
  • Capital Expenditure: 16813000 USD Source
Cash and cash equivalents
4.1 million USD Source
Exact value

4102000 USD

Long-term debt including current maturities
17.2 million USD Source
Exact value

17206000 USD

Shares outstanding
13.2 million shares Source
Exact value

13210122 shares

Reported share-count change

118.74% · 7.17 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 6039208 shares · 2025-06-30· Source
  • 13210122 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

10.8 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Revenue: 4110169 USD · 2025-07-01 – 2025-09-30 Source
  • Revenue: 6547000 USD · 2025-01-01 – 2025-12-31 Source
  • Revenue: 4110169 USD · 2025-01-01 – 2025-09-30 Source
  • Revenue: 2859000 USD · 2026-01-01 – 2026-03-31 Source
  • Revenue: 1365000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-536 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Net income: -216742056 USD · 2025-07-01 – 2025-09-30 Source
  • Net income: -450521000 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: -220837892 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -76264000 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -12818000 USD · 2026-04-01 – 2026-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-26.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 1 of 11 periods available· newest 2025-12-31
  • Operating income: 9 of 11 periods available· newest 2025-12-31
  • Net income: 9 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 9 of 11 periods available· newest 2025-12-31
  • capital expenditure: No compatible figures in this window
  • Total assets: 1 of 11 periods available· newest 2025-12-31
  • Total liabilities: 1 of 11 periods available· newest 2025-12-31
  • Current assets: 1 of 11 periods available· newest 2025-12-31
  • Current liabilities: 1 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 1 of 11 periods available· newest 2025-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 1 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    −USD 436.34 million

    Prior period

    −USD 14.18 million

    –

    Current period

    −USD 450.52 million

    –

    Exact inputs and evidence

    -450521000 − -14180000 = -436341000 USD

    -14180000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -450521000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −USD 24.88 million

    Prior period

    −USD 1.17 million

    –

    Current period

    −USD 26.05 million

    –

    Exact inputs and evidence

    -26052000 − -1171000 = -24881000 USD

    -1171000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -26052000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue USD 6.55 million 100% of revenue
  • Operating costs Derived USD 240 million 3,666% of revenue
  • Operating income −USD 233.45 million −3,566% of revenue
  • Tax, interest and other Derived USD 217.07 million 3,316% of revenue
  • Net income −USD 450.52 million −6,881% of revenue

Cash

  • Operating cash flow −USD 26.05 million −398% of revenue
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2025 Operating loss: operating costs were 3,666% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2025 2025-01-01 – 2025-12-316547000 239997000 Derived -233450000 217071000 Derived -450521000 Unavailable
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 6.5M 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.7.1M5.3M3.5M1.8M0.02025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2025Revenue6547000

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2025Year over yearNo prior comparable period

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -3,565.8% 2025
Net margin -6,881.3% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.551%-1,445%-3,441%-5,436%-7,432%2025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2025Operating margin-3,565.8%
2025Net margin-6,881.3%
2025Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

USD -26.1M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.2.1M-5.5M-13.0M-20.6M-28.1M2025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2025Operating cash flow-26052000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2025Free cash flowUnavailable

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

21.8% 2025
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.23.6%17.7%11.8%5.9%0.0%2025
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2025Liabilities / assets21.8%

Current assets to current liabilities

Current assets divided by current liabilities.

0.33× 2025
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.0.36×0.27×0.18×0.09×0.00×2025
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2025Current assets / current liabilities0.33×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2017 2017-01-01 – 2017-12-31
USD 123,764
Exact value

Exact value: 123764 USD

2017-01-01 – 2017-12-31: 123764 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 497,357
Exact value

Exact value: -497357 USD

2017-01-01 – 2017-12-31: -497357 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2018 2018-01-01 – 2018-12-31
USD 1.04 million
Exact value

Exact value: 1040542 USD

2018-01-01 – 2018-12-31: 1040542 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 789,230
Exact value

Exact value: -789230 USD

2018-01-01 – 2018-12-31: -789230 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2019 2019-01-01 – 2019-12-31
−USD 25.39 million
Exact value

Exact value: -25394046 USD

2019-01-01 – 2019-12-31: -25394046 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 3.32 million
Exact value

Exact value: -3318654 USD

2019-01-01 – 2019-12-31: -3318654 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2020 2020-01-01 – 2020-12-31
−USD 10.88 million
Exact value

Exact value: -10884058 USD

2020-01-01 – 2020-12-31: -10884058 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 3.87 million
Exact value

Exact value: -3871961 USD

2020-01-01 – 2020-12-31: -3871961 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2021 2021-01-01 – 2021-12-31
−USD 20.32 million
Exact value

Exact value: -20324648 USD

2021-01-01 – 2021-12-31: -20324648 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 19.37 million
Exact value

Exact value: -19371428 USD

2021-01-01 – 2021-12-31: -19371428 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2022 2022-01-01 – 2022-12-31
−USD 38.73 million
Exact value

Exact value: -38726259 USD

2022-01-01 – 2022-12-31: -38726259 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 12.13 million
Exact value

Exact value: -12127585 USD

2022-01-01 – 2022-12-31: -12127585 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2023 2023-01-01 – 2023-12-31
−USD 19.94 million
Exact value

Exact value: -19935112 USD

2023-01-01 – 2023-12-31: -19935112 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 10.92 million
Exact value

Exact value: -10922223 USD

2023-01-01 – 2023-12-31: -10922223 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2024 2024-01-01 – 2024-12-31
−USD 14.18 million
Exact value

Exact value: -14180000 USD

2024-01-01 – 2024-12-31: -14180000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.17 million
Exact value

Exact value: -1171000 USD

2024-01-01 – 2024-12-31: -1171000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2025 2025-01-01 – 2025-12-31
−USD 450.52 million
Exact value

Exact value: -450521000 USD

2025-01-01 – 2025-12-31: -450521000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 26.05 million
Exact value

Exact value: -26052000 USD

2025-01-01 – 2025-12-31: -26052000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

89 filings · 2,000 latest values · 2,000 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001690080, 1690080, ATNF, ETHZ, FRMM, KBLM, KBLMU, edgar:1690080

Also known as 180 LIFE SCIENCES CORP, 180 LIFE SCIENCES CORP., 180 Life Sciences Corp., ETHZilla Corp, ETHZilla Corporation, FORUM MARKETS Inc, Forum Markets, Incorporated, KBL MERGER CORP. IV